Rare RAS mutations may not undermine cetuximab benefit in colorectal cancer
A small retrospective study found that metastatic colorectal cancer patients whose tumors carried only rare, non-hotspot RAS or RAF mutations ...
Tag: anti-EGFR therapy
POPULAR NEWS
-
B7-H3 staining patterns in salivary gland carcinomas reveal compartment-specific biomarker clues
-
Day-one MRI after pituitary surgery shows 93% sensitivity for spotting leftover tumor
-
Atomoxetine’s Brain Effects Recreated by a Single Molecular Dial in Whole-Brain Model
-
Senescence-Like States in Sensory Neurons May Explain Why Pain Fails to Resolve